Clinical Trials Directory

Trials / Unknown

UnknownNCT01209975

Retinal Vascular Reactivity in Subjects With Newly Diagnosed Glaucoma Before and After Selective Laser Trabeculoplasty

Retinal Vascular Reactivity in Response to Isoxic Hypercapnia in Subjects With Newly Diagnosed Glaucoma

Status
Unknown
Phase
Study type
Observational
Enrollment
12 (estimated)
Sponsor
University of Toronto · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess retinal blood flow and vascular reactivity in patients with newly diagnosed primary open angle glaucoma pre- and post-primary Selective Laser Trabeculoplasty(SLT). Canon Laser Blood Flowmeter will be used for the assessment of retinal blood flow.

Detailed description

We previously found that vascular reactivity improved after short term treatment with dorzolamide drops. It is not clear whether this improvement was a direct effect of the medication or secondary effect of the decrease in IOP. We would like to see the change of vascular reactivity before and after SLT, which will decrease the intraocular pressure without pharmacologic effect.

Conditions

Interventions

TypeNameDescription
PROCEDURESelective Laser TrabeculoplastyPatient will have selective laser trabeculoplasty as the first treatment for glaucoma. This treatment will be dictated clinically, since we do not assign the interventions.

Timeline

Start date
2008-11-01
Primary completion
2011-11-01
First posted
2010-09-28
Last updated
2010-09-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01209975. Inclusion in this directory is not an endorsement.

Retinal Vascular Reactivity in Subjects With Newly Diagnosed Glaucoma Before and After Selective Laser Trabeculoplasty (NCT01209975) · Clinical Trials Directory